Help create safer, more targeted treatments for cancer by harnessing the power of personalised mRNA medicines.
Imagine a future where doctors can diagnose cancer and swiftly develop a personalised vaccine tailored to combat it within a matter of weeks.
Researchers at the Australian Institute of Bioengineering and Nanotechnology (AIBN) are pioneering this breakthrough using mRNA technology. mRNA cancer vaccines train the body’s immune system to recognise and eradicate cancer cells and can be personalised to each person and their individual cells. These personalised vaccines have shown promising clinical results for several cancer types.
These innovative vaccines hold the potential to revolutionise cancer treatment by providing more effective treatments without the adverse effects of conventional therapies.
Your support today can drive our efforts to design, manufacture and rigorously test new personalised cancer vaccines and lay the foundation to move treatment beyond a one-size-fits-all approach.
Every gift is meaningful.
It is estimated that 2 in 5 people will be diagnosed with cancer by the age of 85. Classified by where they begin in the body, there are more than 100 types of cancer with many being currently untreatable. Early diagnosis and treatment can increase the chance of survival, however current therapies do not distinguish between the healthy and cancerous cells which can create significant and lasting damage to a person’s body and immune system.
The major benefits of mRNA vaccines include increased safety and efficacy as well as streamlined production and scalability, meaning your personal cancer vaccine could be developed much quicker, be cheaper and only target the cancer cells in your body.
The difference you can make.
$500 – could help fund the design of a personalised vaccine candidate.
$1000 – could enable the evaluation of an mRNA vaccine candidate in models of cancer.